Menu Menu

AVBP    Arrivent Biopharma Inc    1868279    
Income Statement
Net Income -20,564,000

Balance Sheet
Current Assets 292,398,000
Assets 292,711,000
Current Liabilities 15,162,000
Liabilities 15,218,000
Equity 277,493,000
Shares Out 33,586,000

Cash Flow Statement
Operating Cash Flow -54,060,000

Market Analysis
Market Cap 825,541,173
Price 24.41
BVPS 8.26
PB 2.95
EPS -2.46
PS 44.43
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
0.25
Apr May Jun
5/08 -0.70
Jul Aug Sep
8/14 -0.65
Oct Nov Dec
11/14

Find a discrepancy? The most accurate way to find company fundamental data is to view AVBP documents filed with the SEC.


AVBP Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: